StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Get Rating) in a report released on Tuesday. The brokerage issued a sell rating on the stock. Navidea Biopharmaceuticals Trading Up 3.7 % Shares of NYSE NAVB opened at $0.25 on Tuesday. Navidea Biopharmaceuticals has a 1-year low of $0.16 and a 1-year high of […]
StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Get Rating) in a research report released on Tuesday morning. The brokerage issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Performance Navidea Biopharmaceuticals stock opened at $0.25 on Tuesday. The stock has a market capitalization of $8.21 million, a price-to-earnings ratio of -0.45 […]
Equities research analysts at StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Get Rating) in a research report issued on Monday. The brokerage set a “sell” rating on the stock. Navidea Biopharmaceuticals Price Performance NYSE NAVB opened at $0.26 on Monday. Navidea Biopharmaceuticals has a fifty-two week low of $0.16 and a fifty-two […]
StockNews.com initiated coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Get Rating) in a report released on Thursday morning. The brokerage issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Performance Shares of NYSE:NAVB opened at $0.28 on Thursday. The company has a market capitalization of $9.03 million, a PE ratio of -0.49 and […]
StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Get Rating) in a report published on Thursday morning. The brokerage issued a sell rating on the stock. Navidea Biopharmaceuticals Trading Up 6.6 % Navidea Biopharmaceuticals stock opened at $0.28 on Thursday. The stock has a 50-day moving average price of $0.30 and a 200 […]